Eugene de Juan

ForSight Labs LLC operates as an ophthalmic technology incubator. It focuses on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. The company was founded by Eugene de Juan, Hanson S. Gifford and Henry A. Plain in 2005 and is headquartered in Menlo Park, CA.

Part of Surmodics, Inc., InnoRx, Inc. designs medical devices. The company is based in Mobile, AL. The company was founded by Eugene de Juan. InnoRx was acquired by Surmodics, Inc. on January 19, 2005 for $17.92 million.

NeoVista, Inc. develops device-based therapy for age-related macular degeneration (AMD). The firm's technology utilizes targeted strontium 90 beta radiation in a one-time surgical procedure and this technology has the possibility to reduce the burden that wet AMD places on healthcare providers, patients, and the healthcare system. The company was founded in 2002 and is headquartered in Newark, CA.

Doheny Eye Institute is a private company that provides research and education programs related to eye care. The company is based in Los Angeles, CA. The CEO of the company is Marissa Goldberg.

ForSight VISION4, Inc. develops novel drug delivery therapies for treatment of retinal diseases. The company was founded on June 26, 009 and is headquartered in Menlo Park, CA.

Nexis Vision, Inc. develops ophthalmic solutions. The company was founded in 2007 and is headquartered in Menlo Park, CA.

Transcend Medical, Inc. operates as a medical device company. It develops medical devices for the treatment of glaucoma, the cause of adult irreversible blindness. The company was founded in 2005 and is headquartered in Lake Forest, CA.

ForSight VISION5, Inc. develops ocular drug delivery technologies and device solutions for ophthalmic diseases. It engages in the development of non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. Its lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to continually receive their medication. The company was founded by Eugene de Juan Jr., J. Andrew Corley and K. Angela Macfarlane in 2010 and is headquartered in Madison, NJ.